195 related articles for article (PubMed ID: 18779312)
1. Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes.
DeVore NM; Smith BD; Urban MJ; Scott EE
Drug Metab Dispos; 2008 Dec; 36(12):2582-90. PubMed ID: 18779312
[TBL] [Abstract][Full Text] [Related]
2. Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes.
DeVore NM; Smith BD; Wang JL; Lushington GH; Scott EE
Drug Metab Dispos; 2009 Jun; 37(6):1319-27. PubMed ID: 19251817
[TBL] [Abstract][Full Text] [Related]
3. Structure of the human lung cytochrome P450 2A13.
Smith BD; Sanders JL; Porubsky PR; Lushington GH; Stout CD; Scott EE
J Biol Chem; 2007 Jun; 282(23):17306-13. PubMed ID: 17428784
[TBL] [Abstract][Full Text] [Related]
4. Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation.
He XY; Shen J; Hu WY; Ding X; Lu AY; Hong JY
Arch Biochem Biophys; 2004 Jul; 427(2):143-53. PubMed ID: 15196988
[TBL] [Abstract][Full Text] [Related]
5. Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine.
DeVore NM; Meneely KM; Bart AG; Stephens ES; Battaile KP; Scott EE
FEBS J; 2012 May; 279(9):1621-31. PubMed ID: 22051186
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
Stephens ES; Walsh AA; Scott EE
Drug Metab Dispos; 2012 Sep; 40(9):1797-802. PubMed ID: 22696418
[TBL] [Abstract][Full Text] [Related]
7. CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline.
Fukami T; Nakajima M; Sakai H; Katoh M; Yokoi T
Drug Metab Dispos; 2007 Mar; 35(3):335-9. PubMed ID: 17178771
[TBL] [Abstract][Full Text] [Related]
8. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes.
DeVore NM; Scott EE
J Biol Chem; 2012 Aug; 287(32):26576-85. PubMed ID: 22700965
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.
Negishi M; Iwasaki M; Juvonen RO; Aida K
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):1031-6. PubMed ID: 22217847
[TBL] [Abstract][Full Text] [Related]
10. Computational insights into the different catalytic activities of CYP2A13 and CYP2A6 on NNK.
Xu Y; Shen Z; Shen J; Liu G; Li W; Tang Y
J Mol Graph Model; 2011 Sep; 30():1-9. PubMed ID: 21680215
[TBL] [Abstract][Full Text] [Related]
11. Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen.
He XY; Shen J; Ding X; Lu AY; Hong JY
Drug Metab Dispos; 2004 Dec; 32(12):1516-21. PubMed ID: 15333516
[TBL] [Abstract][Full Text] [Related]
12. Newly Identified Tree Shrew
Ushirozako G; Noda Y; Murayama N; Kawaguchi H; Tsukiyama-Kohara K; Yamazaki H; Uno Y
Drug Metab Dispos; 2023 May; 51(5):610-617. PubMed ID: 36669854
[TBL] [Abstract][Full Text] [Related]
13. Roles of Human CYP2A6 and Monkey CYP2A24 and 2A26 Cytochrome P450 Enzymes in the Oxidation of 2,5,2',5'-Tetrachlorobiphenyl.
Shimada T; Kakimoto K; Takenaka S; Koga N; Uehara S; Murayama N; Yamazaki H; Kim D; Guengerich FP; Komori M
Drug Metab Dispos; 2016 Dec; 44(12):1899-1909. PubMed ID: 27625140
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism.
von Weymarn LB; Brown KM; Murphy SE
J Pharmacol Exp Ther; 2006 Jan; 316(1):295-303. PubMed ID: 16188955
[TBL] [Abstract][Full Text] [Related]
15. CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6.
von Weymarn LB; Murphy SE
Xenobiotica; 2003 Jan; 33(1):73-81. PubMed ID: 12519695
[TBL] [Abstract][Full Text] [Related]
16. Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol.
Kramlinger VM; von Weymarn LB; Murphy SE
Chem Biol Interact; 2012 May; 197(2-3):87-92. PubMed ID: 22486895
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based inactivation of cytochrome P450 2A6 and 2A13 by Rhinacanthus nasutus constituents.
Pouyfung P; Prasopthum A; Sarapusit S; Srisook E; Rongnoparut P
Drug Metab Pharmacokinet; 2014; 29(1):75-82. PubMed ID: 23903410
[TBL] [Abstract][Full Text] [Related]
18. Oxidations of p-alkoxyacylanilides catalyzed by human cytochrome P450 1A2: structure-activity relationships and simulation of rate constants of individual steps in catalysis.
Yun CH; Miller GP; Guengerich FP
Biochemistry; 2001 Apr; 40(14):4521-30. PubMed ID: 11284709
[TBL] [Abstract][Full Text] [Related]
19. Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes.
Brown PJ; Bedard LL; Reid KR; Petsikas D; Massey TE
Drug Metab Dispos; 2007 Nov; 35(11):2086-94. PubMed ID: 17717079
[TBL] [Abstract][Full Text] [Related]
20. CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ion.
von Weymarn LB; Retzlaff C; Murphy SE
J Pharmacol Exp Ther; 2012 Nov; 343(2):307-15. PubMed ID: 22869927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
